Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Chemed Corp (CHE)
Chemed Corp stock price live, this page displays NYSE CHE stock exchange data. View the CHE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Chemed Corp real time stock price chart below.
What Is the Chemed Corp Stock Price Today?
The Chemed Corp stock price today is 548.28.
What Is the Stock Symbol for Chemed Corp?
The stock symbol for Chemed Corp is "CHE."
What Stock Exchange Does Chemed Corp Trade On?
Chemed Corp is listed and trades on the NYSE stock exchange.
Is Chemed Corp a Good Stock to Buy?
Determining whether Chemed Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHE quote. (ISIN: US16359R1032)
What Is the Chemed Corp Stock Price Today?
The Chemed Corp stock price today is 548.28.
What Is the Stock Symbol for Chemed Corp?
The stock symbol for Chemed Corp is "CHE."
What Stock Exchange Does Chemed Corp Trade On?
Chemed Corp is listed and trades on the NYSE stock exchange.
Is Chemed Corp a Good Stock to Buy?
Determining whether Chemed Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHE quote. (ISIN: US16359R1032)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
530.38
550.31
52 wk Range
365.21
562.24
CHE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
530.38550.31
52 wk Range
365.21562.24
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CHE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
617.00
Upside
+12.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 17 consecutive years
Chemed Corp receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Chemed Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Why is Chemed stock surging today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
2 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 617.00
(+12.53% Upside)
Chemed Corp Earnings Call Summary for Q3/2026
- Chemed Q3 2026 EPS hit $6.75, beating estimates by $0.31; revenue rose 10.6% to $690.9M, topping forecasts by $5.86M; shares surged 9.3% to $556.52.
- VITAS hospice drove growth with revenue up 12.2% and adjusted EBITDA up 31.4% ex-Medicare Cap; average daily census climbed 9.4% to 24,428 patients.
- Roto-Rooter revenue grew 7.5% but margins compressed due to elevated Google lead-generation costs and $1.4M fuel expense increase year-over-year.
- Management expects full-year 2026 adjusted EPS at or above high end of prior guidance; no Medicare Cap limitation forecast for VITAS Florida in 2027.
- Company generated $229M+ operating cash flow through nine months; continued share buybacks and franchise acquisitions with focus on smaller tuck-in deals ahead.
Last Updated: 2026-10-28, 11:16 a/m
Read Full TranscriptEarnings
Latest Release
Oct 27, 2026
EPS / Forecast
6.75 / 6.44
Revenue / Forecast
690.9M / 685.04M
Compare CHE to Peers and Sector
Metrics to compare | CHE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.2x | 33.6x | −0.3x | |
PEG Ratio | 2.34 | 1.72 | 0.00 | |
Price/Book | 8.3x | 4.6x | 2.6x | |
Price / LTM Sales | 2.7x | 1.1x | 2.8x | |
Upside (Analyst Target) | 12.4% | 11.0% | 67.2% | |
Fair Value Upside | Unlock | 3.4% | 10.1% | Unlock |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Chemed (CHE) Stock Price Today?
The Chemed stock price today is 548.28 USD.
What Stock Exchange Does Chemed Trade On?
Chemed is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Chemed?
The stock symbol for Chemed is "CHE."
Does Chemed Pay Dividends? What’s The Current Dividend Yield?
The Chemed dividend yield is 0.5%%.
What Is the Chemed Market Cap?
As of today, Chemed market cap is 7.12B USD.
What Is Chemed's Earnings Per Share (TTM)?
The Chemed EPS (TTM) is 20.96.
When Is the Next Chemed Earnings Date?
Chemed will release its next earnings report on Feb 25, 2027.
From a Technical Analysis Perspective, Is CHE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Chemed Stock Split?
Chemed has split 2 times.
How Many Employees Does Chemed Have?
Chemed has 15811 employees.
What is the current trading status of Chemed (CHE)?
As of Nov 04, 2026, Chemed (CHE) is trading at a price of 548.28 USD, with a previous close of 533.65 USD. The stock has fluctuated within a day range of 530.38 USD to 550.31 USD, while its 52-week range spans from 365.21 USD to 562.24 USD.
What Is Chemed (CHE) Price Target According to Analysts?
The average 12-month price target for Chemed is 617.00 USD, with a high estimate of 675 USD and a low estimate of 580 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +12.53% Upside potential.
What Is the CHE Premarket Price?
CHE's last pre-market stock price is 542.98 USD. The pre-market share volume is 20.00, and the stock has decreased by 9.33, or 1.75%.
What Is the CHE After Hours Price?
CHE's last after hours stock price is 548.64 USD, the stock has decreased by 0.36, or 0.07%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.